Quick Facts
| Legal Status | Since | Adult Use | Access Type | Est. Monthly Cost |
|---|---|---|---|---|
| Legal (Medical — CBD approved) | 2019 (ANVISA regulations) | No | Physician prescription + ANVISA registration (for imports) | BRL 400-2,000/month |
How to Get Medical Cannabis in Brazil
- Consult a physician for a qualifying condition
- For approved CBD products: physician prescription and pharmacy purchase
- For THC-containing products: special ANVISA import authorisation required
- Apply for ANVISA exceptional import authorisation if needed
- Brazil is developing domestic production — more products becoming available
Qualifying Conditions
- Epilepsy (strongest evidence, Epidiolex approved)
- MS
- Chronic pain
- PTSD
- Cancer (nausea/pain)
- Anxiety
Cost & Clinics
Brazil's ANVISA (National Health Surveillance Agency) approved CBD-based medicines in 2019. Epidiolex (cannabidiol) is approved for epilepsy. THC-containing products require exceptional import authorisation. The Brazilian medical cannabis market is growing rapidly with increasing numbers of licensed products. A domestic cultivation framework is being developed.
Frequently Asked Questions
Is medical cannabis legal in Brazil?
Yes — CBD products have been regulated by ANVISA since 2019. THC-containing products require exceptional import authorisation. The market is growing with more licensed products each year.
How do I access medical cannabis in Brazil?
For approved CBD products: physician prescription and pharmacy. For THC products: exceptional ANVISA import authorisation is required — a more complex process.
Which conditions qualify in Brazil?
Epilepsy has the strongest support (Epidiolex approved). Other conditions include MS, chronic pain, PTSD, and cancer-related symptoms.
Is Brazil developing domestic cannabis production?
Yes — a domestic cultivation framework is being developed. Import costs have been a barrier for many patients; domestic production aims to reduce costs.